Saturday, June 10th, 2023
Log in
Logo
Subscribe to Digest
Donate

Elle Wohlmuth

Research
People who have recovered from COVID-19 have antibodies in their blood’s plasma that may help fight the virus. The new treatment, which has been approved as an investigational product by the U.S. Food and Drug Administration, aims to utilize these antibodies by transferring them to patients who are currently battling the virus. (Photo courtesy of Stanford Blood Center)

Stanford Blood Center organizes plasma donation drive for potential COVID-19 treatment

Meghan Sullivan
  •  
April 26, 2020
The Stanford Daily

Login or create an account